Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chiara Micoli

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Pharmaceutical Statistics|November 25, 2025
Simulation-Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case StudiesChiara Micoli, Alessio Crippa, Jason T Connor, et al.
European Urology Oncology|November 17, 2023
Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based StudyLars Egevad, Chiara Micoli, Hemamali Samaratunga, et al.
Pathology|February 9, 2025
Gleason scores provide more accurate prognostic information than grade groupsLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Journal of Clinical Pathology|March 13, 2025
Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancersLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2024
Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based studyLars Egevad, Chiara Micoli, Brett Delahunt, et al.
NEJM Evidence|July 18, 2024
Operative versus Nonoperative Treatment of Proximal Hamstring AvulsionsElsa Pihl, Sofia Laszlo, Anne-Mari Rosenlund, et al.
Annals of Internal Medicine|June 22, 2026
Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-upThorgerdur Palsdottir, Chiara Micoli, Martin Eklund, et al.
European Urology Open Science|November 24, 2025
Can Prostate Cancer Screening Reduce Mortality in Men Aged 75-79 Years? A Protocol for Target-trial EmulationAhmad Abbadi, Chiara Micoli, Andrea Discacciati, et al.
European Urology|October 17, 2025
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 TrialHari T Vigneswaran, Thorgerdur Palsdottir, Chiara Micoli, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Pharmaceutical Statistics|November 25, 2025
Simulation-Based Bayesian Predictive Probability of Success for Interim Monitoring of Clinical Trials With Competing Event Data: Two Case StudiesChiara Micoli, Alessio Crippa, Jason T Connor, et al.
European Urology Oncology|November 17, 2023
Prognosis of Gleason Score 9-10 Prostatic Adenocarcinoma in Needle Biopsies: A Nationwide Population-based StudyLars Egevad, Chiara Micoli, Hemamali Samaratunga, et al.
Pathology|February 9, 2025
Gleason scores provide more accurate prognostic information than grade groupsLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Journal of Clinical Pathology|March 13, 2025
Time trends in Gleason score distribution among Gleason score 8 and 9-10 cancersLars Egevad, Chiara Micoli, Brett Delahunt, et al.
Virchows Archiv : an International Journal of Pathology|April 29, 2024
Prognosis of Gleason score 8 prostatic adenocarcinoma in needle biopsies: a nationwide population-based studyLars Egevad, Chiara Micoli, Brett Delahunt, et al.
NEJM Evidence|July 18, 2024
Operative versus Nonoperative Treatment of Proximal Hamstring AvulsionsElsa Pihl, Sofia Laszlo, Anne-Mari Rosenlund, et al.
Annals of Internal Medicine|June 22, 2026
Stockholm3-Magnetic Resonance Imaging Population-Based Prostate Cancer Screening Study: Two-Year Follow-upThorgerdur Palsdottir, Chiara Micoli, Martin Eklund, et al.
European Urology Open Science|November 24, 2025
Can Prostate Cancer Screening Reduce Mortality in Men Aged 75-79 Years? A Protocol for Target-trial EmulationAhmad Abbadi, Chiara Micoli, Andrea Discacciati, et al.
European Urology|October 17, 2025
Stockholm3 Versus Prostate-specific Antigen in Prostate Cancer Screening: 9-year Outcomes Demonstrating Improved Detection of Aggressive Cancers and Reduced Overdiagnosis from the STHLM3 TrialHari T Vigneswaran, Thorgerdur Palsdottir, Chiara Micoli, et al.
Pageof 1